Charles River Laboratories
CRL
611 hedge funds and large institutions have $10.7B invested in Charles River Laboratories in 2023 Q2 according to their latest regulatory filings, with 66 funds opening new positions, 251 increasing their positions, 203 reducing their positions, and 74 closing their positions.
24% more repeat investments, than reductions
Existing positions increased: 251 | Existing positions reduced: 203
5% more capital invested
Capital invested by funds: $10.3B → $10.7B (+$469M)
0.05% less ownership
Funds ownership: 99.95% → 99.9% (-0.05%)
2% less funds holding
Funds holding: 621 → 611 (-10)
11% less first-time investments, than exits
New positions opened: 66 | Existing positions closed: 74
16% less call options, than puts
Call options by funds: $29.3M | Put options by funds: $34.8M
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$81.8M |
| 2 |
AI
Ariel Investments
Chicago,
Illinois
|
+$72.6M |
| 3 |
ClearBridge Investments
New York
|
+$68.3M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$50.8M |
| 5 |
MBI
Montrusco Bolton Investments
Montreal,
Quebec, Canada
|
+$43.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$105M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$79.5M |
| 3 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$62.2M |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
-$60M |
| 5 |
FAM
Fred Alger Management
New York
|
-$44.1M |
CRL Hedge Fund Activity: Q2 2023 in Review
611 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q2 2023, worth a combined $10.7B — up 4.6% from $10.3B a quarter earlier.
Sellers outnumbered buyers: 74 funds closed out of CRL and 66 opened new positions — a net loss of 8 holders — while 203 trimmed existing stakes and 251 added.
The largest buyer was BlackRock, adding an estimated $81.8M. The largest seller was Marshall Wace, cutting an estimated $105M.
- 611 institutional investors held Charles River Laboratories (CRL) as of Q2 2023, down from 621 in Q1 2023.
- Funds reported $10.7B of Charles River Laboratories stock for Q2 2023, up 4.6% quarter-over-quarter.
- 66 funds opened new Charles River Laboratories positions in Q2 2023 and 74 closed out, a net change of -8 holders.
- The largest Charles River Laboratories buyer in Q2 2023 was BlackRock, an estimated $81.8M added.
- The largest Charles River Laboratories seller in Q2 2023 was Marshall Wace, an estimated $105M sold.
Based on aggregated 13F filings for Q2 2023.